Arrhythmia Market

Global Arrhythmia Market Size, Trends & Analysis - Forecasts to 2026 By Type (Extra Beats, Ventricular Arrhythmias, Supraventicular Tachycardias, Bradyarrhythmias), By Test Equipment (Holter Monitor, Electrocardiogram (ECG)), By Site Of Origin (Premature Atrial Contractions (PACS), Sinus Bradycardia, Atrial Tachycardia, Wandering Atrial Pacemaker, Supraventricular Tachycardia (SVT), Multifocal Atrial Tachycardia, Atrial Fibrillation (AFIB), Atrial Flutter), By Heart Blocks (First Degree Heart Block, Second Degree Heart Block, Third Degree Heart Block), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 17 2024 with the latest and most recent market numbers

Arrhythmia Market Size

The Global Arrhythmia Market is projected to grow at a CAGR value of 6.2% from 2021 to 2026. An arrhythmia is defined as a complication with the rate of the patient’s heartbeat or irregularities in the rhythm of the heart. The heart of a person suffering from arrhythmia can often beat at a slower pace, or at times too fast, or with an irregular rhythm. When the heart rate is faster than normal, the condition is termed tachycardia. When the heart beats at a slow speed too much, the condition is termed bradycardia.

Arrhythmia is mainly caused by alterations in the tissue of the heart. It can also happen suddenly due to stress or exertion, medicines, irregularities in the blood, or problems with electrical signs in the heart. Usually, a kind of trigger sets off an arrhythmia, and the unusual heartbeat may persist if there is a problem in the heart. Seldom the origin of arrhythmia is not known.

Determinants such as the growing number of instances of lifestyle practices such as smoking and excessive alcohol consumption being adopted, increasing occurrences of obesity, which ultimately makes a body more susceptive to cardiac arrhythmias, and the rising levels of awareness in patients, globally are driving the growth of the arrhythmia market.

The other driving determinants are the accelerating economic growth, growing consumption of tobacco, rising expenditure on healthcare services, escalation of the obese population, the rise of irrigated radiofrequency (RF) ablation catheter devices, and the rising predominance of cardiac arrhythmias.

global arrhythmia market

Arrhythmia Market: By Type

Based on the type, the market is segmented into extra beats, ventricular arrhythmias, supraventricular tachycardias, and bradyarrhythmias.

The extra beats segment will hold a significant market share in the forecast period. This can be attributed to the reality that the extra beats type of arrhythmia is the most common kind of arrhythmia. An untimely heartbeat occurs when the sign of beating comes early. It can feel as if the heart has skipped a beat. The premature or extra heartbeat generates a short pause, which is then followed by a much stronger beat when the heart reverts to its normal rhythm. These are termed ectopic heartbeats, and they can trigger other types of arrhythmias.

Arrhythmia Market: By Test Equipment

Based on the test equipment used to diagnose an arrhythmia, the market is segmented into holter monitor and electrocardiogram (ECG).

The electrocardiogram (ECG) segment will hold the largest market share in the forecast period. The most common test equipment used for the diagnosis of arrhythmia is an electrocardiogram (EKG or ECG). The electrocardiogram (EKG or ECG) helps to see how speedily the heart is beating and whether the beat is irregular or steady.

Holter or event monitor is used to record the electrical activity of the heart over long periods while the patient does normal activities.

Arrhythmia Market: By Site of Origin

Based on the site of the origin, the market is segmented into premature atrial contractions (PACS), sinus bradycardia, atrial tachycardia, wandering atrial pacemaker, supraventricular tachycardia (SVT), multifocal atrial tachycardia, atrial fibrillation (AFIB), and atrial flutter.

The atrial fibrillation segment will hold a significant share over the forecast period. This can be attributed to the reality that atrial fibrillation, which is a type of supraventricular arrhythmias, is one of the most common kinds of arrhythmia. Atrial fibrillation is an abnormal and often rapid heartbeat occurring when the working of the two upper chambers of the heart experience a disruption in their received electrical signs. The outcome is a speedy and irregular heartbeat.

Arrhythmia Market: By Heart Blocks

The market is segmented into first-degree heart block, second-degree heart block, and third-degree heart block, based on the heart blocks.

The second-degree heart block segment will hold the maximum market share during the forecast period. In the case of type 2 or Mobitz II second-degree atrioventricular block, the PR interval remains consistent. The heartbeats are intermittently non-conducted, and QRS complexes are dropped, normally in a repetitious cycle of every 3rd or 4th P wave.

Maximum patients with congenital third-degree atrioventricular block have a junctional escape beat that sustains a fair rate, but they need a permanent pacemaker before reaching middle age. It is less common for patients with congenital atrioventricular block to have a slow escape beat and need a permanent pacemaker at a tender age, possibly even during infancy.

asia pacific arrhythmia market

Arrhythmia Market: By Region

As per the geographical analysis, the arrhythmia market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America).

In the South American region and the Asia Pacific region, the escalating population of patients with congestive heart failure (CHF) conditions and cardiac arrhythmias is anticipated to propel the arrhythmia market in the forecast period.

The high unmet medical requirements and continually enhancing healthcare infrastructure in emerging Latin American and Asian regions are anticipated to drive the arrhythmia market exponentially.

Arrhythmia Market Share and Competitor Analysis

Biotronik, GE Healthcare, OSI Systems (Spacelabs Healthcare), Mylan N.V., Medtronic, NUUBO Smart Solutions Technologies, Teva Pharmaceutical Industries, Abbott Laboratories (St. Jude Medical), Mayne Pharma, Fukuda Denshi, Nihon Kohden, GlaxoSmithKline LLC, Philips Healthcare, Sanofi S.A., Upsher-Smith Laboratories LLC, Hill-Rom (Welch Allyn), Novartis International AG, BioTelemetry, are some of the key players in the arrhythmia market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Arrhythmia Industry Overview, 2020-2026

2.1.1 Industry Overview

2.1.2 Type Overview

2.1.3 Test Equipment Overview

2.1.4 Site of Origin Overview

2.1.5 Heart Blocks Overview

2.1.6 Regional Overview

Chapter 3 Arrhythmia Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2020-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Advancements in the diagnostic techniuqes

3.3.1.2 Growing geriatric population in APAC region

3.3.2 Industry Challenges

3.3.2.1 Lack of adequate infrastructure in developing nations

3.4 Prospective Growth Scenario

3.4.1 Type Growth Scenario

3.4.2 Test Equipment Growth Scenario

3.4.3 Site of Origin Growth Scenario

3.4.4 Heart Blocks Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Heart Blocks Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Arrhythmia Market, By Type

4.1 Type Outlook

4.2 Extra Beats

4.2.1 Market Size, By Region, 2020-2026 (USD Million)

4.3 Ventricular Arrhythmias

4.3.1 Market Size, By Region, 2020-2026 (USD Million)

4.4 Supraventricular Tachycardias

4.4.1 Market Size, By Region, 2020-2026 (USD Million)

4.5 Bradyarrhythmia

4.5.1 Market Size, By Region, 2020-2026 (USD Million)

Chapter 5 Arrhythmia Market, By Site of Origin

5.1 Site of Origin Outlook

5.2 Premature Atrial Contractions (PACS)

5.2.1 Market Size, By Region, 2020-2026 (USD Million)

5.3 Sinus Bradycardia

5.3.1 Market Size, By Region, 2020-2026 (USD Million)

5.4 Atrial Tachycardia

5.4.1 Market Size, By Region, 2020-2026 (USD Million)

5.5 Wandering Atrial Pacemaker

5.5.1 Market Size, By Region, 2020-2026 (USD Million)

5.6 Supraventricular Tachycardia (SVT)

5.6.1 Market Size, By Region, 2020-2026 (USD Million)

5.7 Multifocal Atrial Tachycardia

5.7.1 Market Size, By Region, 2020-2026 (USD Million)

5.8 Atrial Fibrillation (AFIB)

5.8.1 Market Size, By Region, 2020-2026 (USD Million)

5.9 Atrial Flutter

5.9.1 Market Size, By Region, 2020-2026 (USD Million)

Chapter 6 Arrhythmia Market, By Test Equipment

6.1 Holter Monitor

6.1.1 Market Size, By Region, 2020-2026 (USD Million)

6.2 Electrocardiogram (ECG)

6.2.1 Market Size, By Region, 2020-2026 (USD Million)

Chapter 7 Arrhythmia Market, By Heart Blocks

7.1 First Degree Heart Block

7.1.1 Market Size, By Region, 2020-2026 (USD Million)

7.2 Second Degree Heart Block

7.2.1 Market Size, By Region, 2020-2026 (USD Million)

7.3 Third Degree Heart Block

7.3.1 Market Size, By Region, 2020-2026 (USD Million)

Chapter 8 Arrhythmia Market, By Region

8.1 Regional outlook

8.2 North America

8.2.1 Market Size, By Country 2020-2026 (USD Million)

8.2.2 Market Size, By Type, 2020-2026 (USD Million)

8.2.3 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.2.4 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.2.5 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.2.6 U.S.

8.2.6.1 Market Size, By Type, 2020-2026 (USD Million)

8.2.4.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.2.4.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.2.7 Canada

8.2.7.1 Market Size, By Type, 2020-2026 (USD Million)

8.2.7.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.2.7.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.2.7.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.3 Europe

8.3.1 Market Size, By Country 2020-2026 (USD Million)

8.3.2 Market Size, By Type, 2020-2026 (USD Million)

8.3.3 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.3.4 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.3.5 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.3.6 Germany

8.3.6.1 Market Size, By Type, 2020-2026 (USD Million)

8.3.6.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.3.6.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.3.6.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.3.7 UK

8.3.7.1 Market Size, By Type, 2020-2026 (USD Million)

8.3.7.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.3.7.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.3.7.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.3.8 France

8.3.8.1 Market Size, By Type, 2020-2026 (USD Million)

8.3.8.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.3.8.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.3.8.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.3.9 Italy

8.3.9.1 Market Size, By Type, 2020-2026 (USD Million)

8.3.9.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.3.9.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.3.9.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.3.10 Spain

8.3.10.1 Market Size, By Type, 2020-2026 (USD Million)

8.3.10.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.3.10.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.3.10.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.3.11 Russia

8.3.11.1 Market Size, By Type, 2020-2026 (USD Million)

8.3.11.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.3.11.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.3.11.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.4 Asia Pacific

8.4.1 Market Size, By Country 2020-2026 (USD Million)

8.4.2 Market Size, By Type, 2020-2026 (USD Million)

8.4.3 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.4.4 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.4.5 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.4.6 China

8.4.6.1 Market Size, By Type, 2020-2026 (USD Million)

8.4.6.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.4.6.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.4.6.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.4.7 India

8.4.7.1 Market Size, By Type, 2020-2026 (USD Million)

8.4.7.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.4.7.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.4.7.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.4.8 Japan

8.4.8.1 Market Size, By Type, 2020-2026 (USD Million)

8.4.8.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.4.8.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.4.8.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.4.9 Australia

8.4.9.1 Market Size, By Type, 2020-2026 (USD Million)

8.4.9.2 Market size, By Test Equipment, 2020-2026 (USD Million)

8.4.9.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.4.9.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.4.10 South Korea

8.4.10.1 Market Size, By Type, 2020-2026 (USD Million)

8.4.10.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.4.10.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.4.10.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.5 Latin America

8.5.1 Market Size, By Country 2020-2026 (USD Million)

8.5.2 Market Size, By Type, 2020-2026 (USD Million)

8.5.3 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.5.4 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.5.5 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.5.6 Brazil

8.5.6.1 Market Size, By Type, 2020-2026 (USD Million)

8.5.6.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.5.6.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.5.6.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.5.7 Mexico

8.5.7.1 Market Size, By Type, 2020-2026 (USD Million)

8.5.7.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.5.7.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.5.7.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.5.8 Argentina

8.5.8.1 Market Size, By Type, 2020-2026 (USD Million)

8.5.8.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.5.8.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.5.8.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.6 MEA

8.6.1 Market Size, By Country 2020-2026 (USD Million)

8.6.2 Market Size, By Type, 2020-2026 (USD Million)

8.6.3 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.6.4 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.6.5 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.6.6 Saudi Arabia

8.6.6.1 Market Size, By Type, 2020-2026 (USD Million)

8.6.6.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.6.6.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.6.6.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.6.7 UAE

8.6.7.1 Market Size, By Type, 2020-2026 (USD Million)

8.6.7.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.6.7.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.6.7.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

8.6.8 South Africa

8.6.8.1 Market Size, By Type, 2020-2026 (USD Million)

8.6.8.2 Market Size, By Test Equipment, 2020-2026 (USD Million)

8.6.8.3 Market Size, By Site of Origin, 2020-2026 (USD Million)

8.6.8.4 Market Size, By Heart Blocks, 2020-2026 (USD Million)

Chapter 9 Company Landscape

9.1 Competitive Analysis, 2020

9.2 Medtronic

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Positioning

9.2.4 Info Graphic Analysis

9.3 NUUBO Smart Solutions Technologies

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Positioning

9.3.4 Info Graphic Analysis

9.4 Teva Pharmaceutical Industries

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Positioning

9.4.4 Info Graphic Analysis

9.5 Abbott Laboratories

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Positioning

9.5.4 Info Graphic Analysis

9.6 Mayne Pharma

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Positioning

9.6.4 Info Graphic Analysis

9.7 Fukuda Denshi

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Positioning

9.7.4 Info Graphic Analysis

9.8 Nihon Kohden

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Positioning

9.8.4 Info Graphic Analysis

9.9 GlaxoSmithKline LLC

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Positioning

9.9.4 Info Graphic Analysis

9.10 Philips Healthcare

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Positioning

9.10.4 Info Graphic Analysis

9.11 Other Companies

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Strategic Positioning

9.11.4 Info Graphic Analysis

The Global Arrhythmia Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Arrhythmia Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global arrhythmia market?

The global arrhythmia market size is projected to grow at a CAGR of 6.2% % from 2021 to 2026.

Who are the major vendors in the arrhythmia market?

Medtronic, NUUBO Smart Solutions Technologies, Teva Pharmaceutical Industries, Abbott Laboratories (St. Jude Medical), Mayne Pharma, Fukuda Denshi, Nihon Kohden, GlaxoSmithKline LLC, Philips Healthcare, Sanofi S.A., Upsher-Smith Laboratories LLC, Hill-Rom (Welch Allyn), Novartis International AG, BioTelemetry, Biotronik, GE Healthcare, OSI Systems (Spacelabs Healthcare), Mylan N.V., among others are the top players in the arrhythmia market.

Which region has the highest market share in the arrhythmia market?

The North American region is estimated to hold the largest share of the arrhythmia market.

What is the Covid-19 impact on the future of the arrhythmia market?

During the COVID-19 lockdowns, the volume of tests and treatment being conducted to test and treat for arrythmia lowered as hospitals began prioritising high risk and COVID patients. COVID-related copmlications and the unmet demand for testing and treatment is expected drive the market in the post pandemic period.

What are the major drivers in the arrhythmia market?

Determinants such as the growing number of instances of lifestyle practices such as smoking and excessive alcohol consumption being adopted, increasing occurrences of obesity, which ultimately makes a body more susceptive to cardiac arrhythmias, the rising levels of awareness in patients, and growing geriatric population globally are driving the growth of the arrhythmia market